More Globe Newswire

View Older Stories View Newer Stories

Feb 20, 2025 08:00AM BriteCore Solution Marketplace Expands with Five New Vendor Integrations
Feb 20, 2025 08:00AM Tectonic Therapeutic to Participate in March Investor Conferences
Feb 20, 2025 08:00AM City of Columbus Selects Voltus as its Exclusive Demand Response Provider
Feb 20, 2025 08:00AM Aterian Issues Letter to Shareholders
Feb 20, 2025 08:00AM Orchestra BioMed to Present at Upcoming Investor Conferences
Feb 20, 2025 08:00AM FAVO Capital to Attend 14th Annual Global Fund Finance Symposium in Miami
Feb 20, 2025 08:00AM Growth in Originations Expected Across Multiple Credit Products in 2025
Feb 20, 2025 08:00AM T-knife Therapeutics Welcomes Dr. Sophie Papa to its Board of Directors
Feb 20, 2025 08:00AM HighSpeedInternet.com Releases Fifth Annual Internet Service Provider (ISP) Review
Feb 20, 2025 08:00AM UPSTACK Acquires IT Advisory Firm V3 Technology
Feb 20, 2025 08:00AM DIRECTV Advertising and Magnite Enhance Live Streaming Programmatic Demand During Peak Viewing Events
Feb 20, 2025 08:00AM STACK Infrastructure Appoints Matt VanderZanden as President
Feb 20, 2025 08:00AM Fiverr Launches a Freelancer Equity Program to Give Direct Stake in the Business
Feb 20, 2025 08:00AM Pacira to Report 2024 Financial Results on Thursday February 27, 2025
Feb 20, 2025 08:00AM Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Feb 20, 2025 08:00AM EPKINLY® (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare for Additional Indication as a Treatment for Relapsed or Refractory Follicular Lymphoma
Feb 20, 2025 08:00AM Natural gas remains the crucial bridge in the energy transition, yet challenges persist
Feb 20, 2025 07:37AM Interim Management Report covering H1 2024/25
Feb 20, 2025 07:37AM ParaZero Unlocks Growth Opportunities After Achieving European Regulatory Compliance for its SafeAir Systems
Feb 20, 2025 07:32AM Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favo
Feb 20, 2025 07:30AM Gold-Rich Cobalt-Copper Mineralization at CAS Property Strengthens Electra’s Idaho Exploration Strategy
Feb 20, 2025 07:30AM Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Feb 20, 2025 07:30AM FTI Consulting Reports Fourth Quarter and Full Year 2024 Financial Results
Feb 20, 2025 07:30AM Repligen Reports Fourth Quarter and Full Year 2024 Financial Results
Feb 20, 2025 07:30AM Labrador Gold Announces 2025 Exploration Programs for the 100% Owned Hopedale and Borden Lake Gold Projects
Feb 20, 2025 07:30AM Mandalay Resources Reports 2024 Mineral Reserves and Resources Approaching Two Million Gold Equivalent Ounces in Measured and Indicated Resources
Feb 20, 2025 07:30AM Global Crossing Airlines Sets Fourth Quarter and Full Year 2024 Conference Call for March 6, 2025 at 8:30 a.m. ET
Feb 20, 2025 07:30AM Rekor Systems to Announce 2024 Results
Feb 20, 2025 07:30AM Western Upper Peninsula Communities Demonstrate Continued Support for the Copperwood Mine Project
Feb 20, 2025 07:30AM VR Resources Completes Drilling at Silverback Copper-Gold Project in Northwest Ontario
Feb 20, 2025 07:30AM Plus Therapeutics Appoints Dr. Michael Rosol as Chief Development Officer
Feb 20, 2025 07:30AM BT Group Advances Enterprise Service Innovation by Enabling Future-Proven Business Services With Optiva Platform
Feb 20, 2025 07:30AM Purpose Investments Expands Yield Shares Lineup with Seven New ETFs, Offering Enhanced Income Opportunities
Feb 20, 2025 07:30AM NowVertical Completes Debt-to-Equity Conversions
Feb 20, 2025 07:30AM Altimmune to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on February 27, 2025
Feb 20, 2025 07:30AM Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences
Feb 20, 2025 07:30AM Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer’s Candidate, Zervimesine (CT1812)
Feb 20, 2025 07:30AM Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2024 Earnings and Company Updates
Feb 20, 2025 07:30AM Colliers makes 19th consecutive appearance on IAOP’s Global Outsourcing 100
Feb 20, 2025 07:30AM BridgeBio Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Commercial Update
Feb 20, 2025 07:30AM Laureate Education Reports Financial Results for the Fourth Quarter and Full-Year 2024 and Provides 2025 Outlook
Feb 20, 2025 07:30AM MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements
Feb 20, 2025 07:30AM Rekor Systems to Announce 2024 Results
Feb 20, 2025 07:30AM CoreCard Corporation Reports Fourth Quarter and Full Year 2024 Results
Feb 20, 2025 07:30AM Codere Online Reports Financial Results for the Fourth Quarter and Full Year 2024
Feb 20, 2025 07:29AM Altisource Announces Closing of the Previously Announced Exchange and Maturity Extension Transactions of the Company’s Term Loans
Feb 20, 2025 07:27AM COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
Feb 20, 2025 07:27AM COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
Feb 20, 2025 07:22AM PayPoint plc : Holding(s) in Company
Feb 20, 2025 07:15AM AS Tallink Grupp Investor Webinar introducing the results of the Q4 and 12 months of 2024
View Newer Stories View Older Stories